Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$1.16
+1.8%
$1.07
$0.71
$1.61
$72.80M1.19324,084 shs39,034 shs
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
$0.20
$0.09
$0.00
$3.40
$20.65M-17.745,371 shsN/A
Nutriband Inc. stock logo
NTRB
Nutriband
$6.57
+4.3%
$7.83
$3.72
$11.78
$73.28M1.13200,118 shs38,245 shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.25
-1.6%
$1.34
$0.91
$1.80
$74.06M2.99159,676 shs96,875 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%+16.00%+17.17%+28.89%+18.37%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
0.00%+99,900.00%+45.99%-1.23%-20.00%
Nutriband Inc. stock logo
NTRB
Nutriband
0.00%-8.37%-15.34%+16.90%+10.05%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
0.00%-9.42%-21.38%+21.36%-0.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.1496 of 5 stars
3.33.00.00.02.80.00.6
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/AN/AN/AN/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
3.293 of 5 stars
3.55.00.00.02.51.70.6
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2.1757 of 5 stars
3.53.00.00.01.71.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.50
Moderate Buy$5.50374.14% Upside
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
0.00
N/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.0097.87% Upside
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
3.00
Buy$4.00220.00% Upside

Current Analyst Ratings Breakdown

Latest HYBT, VANI, NTRB, and CTSO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
7/21/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
6/25/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/19/2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00 ➝ $4.00
(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$35.60M2.04N/AN/A$0.18 per share6.44
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
$80K258.12N/AN/A$0.38 per share0.53
Nutriband Inc. stock logo
NTRB
Nutriband
$2.40M30.55N/AN/A$0.58 per share11.33
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/A$0.08 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$20.72M-$0.17N/AN/AN/A-25.58%-111.97%-29.00%N/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
-$270KN/A0.00N/A-453.55%-6.43%-4.43%N/A
Nutriband Inc. stock logo
NTRB
Nutriband
-$10.48M-$0.90N/AN/AN/A-415.93%-68.25%-60.40%9/2/2025 (Estimated)
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$23.49M-$0.45N/AN/AN/AN/A-194.66%-68.64%N/A

Latest HYBT, VANI, NTRB, and CTSO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/2/2025N/A
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.17N/AN/AN/A$0.71 millionN/A
8/13/2025Q2 2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.10-$0.12-$0.02-$0.12N/AN/A
8/7/2025Q2 2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.07-$0.05+$0.02$0.03$9.79 million$9.62 million
5/30/2025Q1 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
1.24
2.34
2.30
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/A
0.35
0.34
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
3.71
3.48
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/A
1.30
2.40

Institutional Ownership

CompanyInstitutional Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/A
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
6.78%

Insider Ownership

CompanyInsider Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
7.30%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
89.24%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
46.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.76 million58.18 millionOptionable
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
6103.25 million11.11 millionNot Optionable
Nutriband Inc. stock logo
NTRB
Nutriband
1011.15 million5.12 millionNot Optionable
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2059.24 million31.76 millionOptionable

Recent News About These Companies

Vivani closes $10M financing, advances GLP-1 implant
Vivani Medical (NASDAQ:VANI) Stock Price Down 0.8% Following Weak Earnings
3 Penny Stocks With Market Caps Over $30M To Consider
Companies To Watch: Vivani Medical

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$1.16 +0.02 (+1.75%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$1.11 -0.05 (-4.66%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Heyu Biological Technology stock logo

Heyu Biological Technology OTCMKTS:HYBT

$0.20 0.00 (0.00%)
As of 08/15/2025

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$6.57 +0.27 (+4.29%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$6.49 -0.08 (-1.28%)
As of 08/15/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Vivani Medical stock logo

Vivani Medical NASDAQ:VANI

$1.25 -0.02 (-1.57%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$1.26 +0.01 (+0.80%)
As of 08/15/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.